Knocking down of lncUSMycN expression was shown to reduce MYCN at the mRNA and protein level, thereby inhibiting MNA NB cell proliferation and tumor growth in in vitro and in vivo NB models, respectively [136]. The gene discussed is MYCN; the disease is neuroblastoma.